MarketPeel
Insider Trading Intelligence
Pricing
…
SS

Stefan K.f. Schwabe

SUPN
EXECUTIVE VICE PRESIDENT & CMO · SUPERNUS PHARMACEUTICALS, INC. · CIK 0001557657
FILING MIX · LIFETIME40%/60%
BUYS
4
SELLS
6
TOTAL VALUE
$3.30M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
49,119
AVG SELL PX
$21.98
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Stefan K.f. Schwabe, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+0.00%+6.17%+1.26%+4.91%+2.11%—
14d3+0.00%+14.38%+1.75%+12.63%+13.01%—
30d3+0.00%+30.37%+4.51%+25.86%+25.62%—
60d3+0.00%+38.03%+7.43%+30.60%+32.88%—
90d3+0.00%+23.01%+8.47%+14.55%+14.45%—
180d3+0.00%+43.65%+16.00%+27.65%+26.68%—
1y3+0.00%+30.78%+28.42%+2.36%+1.13%—
2y3+0.00%+65.70%+11.21%+54.49%+51.31%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SUPN · 49,119 shares · as of Dec 21, 2020
014,10628,21342,31956,425SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
FLOW · 4 buys / 6 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
46,347——0Dec 21, 2020Dec 22, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
46,347$22.10$1.02M2,772Dec 21, 2020Dec 22, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CMO
46,347$12.98$601.6K49,119Dec 21, 2020Dec 22, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
50,000$21.86$1.09M6,425Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
3,653$22.00$80.4K2,772Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
3,653——46,347Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CMO
50,000$9.13$456.5K52,772Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
Executive Vice President & CMO
50,000——0Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CMO
3,653$12.98$47.4K56,425Dec 14, 2020Dec 15, 2020 ↗
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,000——50,000Feb 21, 2020Feb 25, 2020 ↗
Other insiders · SUPN
Loading peer insiders…
About this filer
CIK 0001557657
ROLE
Executive Vice President & CMO
PRIMARY
SUPN
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001557657DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackStefan K.f. Schwabe — Insider Trading Activity | MarketPeel